Precigen (PGEN) Asset Writedowns and Impairment (2016 - 2024)

Precigen (PGEN) has disclosed Asset Writedowns and Impairment for 10 consecutive years, with -$32.9 million as the latest value for Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to -$32.9 million in Q4 2024 year-over-year; TTM through Sep 2025 was -$32.9 million, a N/A change, with the full-year FY2022 number at $944000.0, down 25.55% from a year prior.
  • Asset Writedowns and Impairment was -$32.9 million for Q4 2024 at Precigen, down from $306000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $12.6 million in Q3 2020 to a low of -$32.9 million in Q4 2024.
  • A 4-year average of -$1.6 million and a median of $306000.0 in 2022 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 1920.29% in 2020, then plummeted 94.65% in 2021.
  • Precigen's Asset Writedowns and Impairment stood at $12.6 million in 2020, then plummeted by 99.61% to $49000.0 in 2021, then surged by 524.49% to $306000.0 in 2022, then crashed by 10856.54% to -$32.9 million in 2024.
  • Per Business Quant, the three most recent readings for PGEN's Asset Writedowns and Impairment are -$32.9 million (Q4 2024), $306000.0 (Q3 2022), and $304000.0 (Q2 2022).